GVK Biosciences | Zee News

Advertisement

NewsGVK Biosciences

GVK Biosciences News

30 Dec 2015

GVK Biosciences row: India, EU to meet on Jan 18 in Brussels

India and EU are expected to meet on January 18 in Brussels.

Foreign Investment Promotion Board

27 Nov 2015

FIPB clears 3 FDI proposals worth Rs 160 crore

The foreign investment promotion board today cleared three FDI proposals worth Rs 160 crore.

22 Aug 2015

Germany suspends marketing of 54 drugs tested by India's GVK Bio

Germany has suspended marketing of 54 drugs tested by GVK Biosciences in compliance with the European Union's ban on around 700 generic drugs.

07 Aug 2015

Drug ban not trade related, hopeful of solution: EU

The EU Friday defended the banning of around 700 generic drugs tested by India's GVK Biosciences, asserting it was based on "scientific and not trade considerations" and voiced hope that a solution will be found after India deferred FTA talks with the bloc over the issue.

05 Aug 2015

India defers FTA talks with EU over ban of 700 pharma products

Expressing disappointment and concern over the EU banning sale of around 700 pharma products clinically tested by GVK Biosciences, India has deferred the talks with the European Union on the proposed free trade agreement.

27 Jul 2015

EU suspends sale of 700 generic drugs made in India

European Union nations have until August 20 to suspend the sale of some 700 generic drugs made in India, the EU`s executive confirmed on Monday.

25 Jul 2015

EU bans 700 generic drugs for manipulation of trials by GVK

The European Union has banned the marketing of around 700 generic medicines for alleged manipulation of clinical trials conducted by India's pharmaceutical research company GVK Biosciences.

GVK Biosciences

16 Jun 2015

Swedish pharma firm partners GVK Bio for drug research

Sweden-based pharmaceutical firm Medivir has entered into a partnership with GVK Biosciences for drug research.

GVK Biosciences

06 Feb 2015

Swissmedic examines drugs trialled by GVK Biosciences

The Swiss surveillance authority for medicines Friday checked for any corresponding preparations of the 700 generic medicines subjected to clinical trials by India's GVK Biosciences, whose marketing rights were suspended by the European Medicines Agency (EMA).

GVK Biosciences

24 Jan 2015

German regulator hails EMA's drugs suspension on GVK Bio data

German drug regulator has welcomed the European Medicine Agency's (EMA) decision to suspend the marketing authorisation of around 700 generic drugs subjected to clinical trials by India's GVK Biosciences.

08 Dec 2014

GVK Bio offers to re-do studies after EU ruling

Pharmaceutical research company GVK Biosciences has offered to re-do studies at its own cost after the European Union suspended marketing approval of some generic drugs due to alleged manipulation of data related to clinical trials.

06 Dec 2014

France, Germany suspend some drug approvals over Indian data

All of the drugs being suspended, several of which are manufactured by Mylan Inc and Abbott , have brand name equivalents that can be used instead, so patients will not have to interrupt their treatment.

GVK Biosciences

01 Oct 2014

GVK Bio under scanner of European Drug Regulator

The European Medicines Agency (EMA) has started a review in connection with findings of alleged non-compliance with good clinical practice (GCP) at a facility owned by GVK Biosciences, a city-based Contract Research Organisation.

Loading...

NEWS ON ONE CLICK